NCT04052412View on ClinicalTrials.gov

Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer

PHASE1UnknownINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

18F-AraG

All arms of the study will receive an injection of 18F-AraG while on the PET imaging system. Following a 6 minute scan over the heart to acquire input function data, the patient will undergo a 1 hour multi-pass whole-body dynamic PET/CT acquisition to gather whole-body biodistribution data.

Trial Locations (1)

37920

RECRUITING

University of Tennessee Medical Center, Knoxville

Sponsors
All Listed Sponsors
collaborator

CellSight Technologies, Inc.

INDUSTRY

lead

University of Tennessee

OTHER